-
Haemorheological adaptation during pregnancy in a Latin American population.
Kametas N, Krampl E, McAuliffe F, Rampling MW, Nicolaides KH.
Eur J Haematol 2001;66:305-11. -
Placental villus morphology in relation to maternal hypoxia at high altitude.
Espinoza J, Sebire NJ, McAuliffe F, Krampl E, Nicolaides KH.
Placenta 2001;22:606-8. -
Absence of nasal bone in fetuses with trisomy 21 at 11-14 weeks of gestation: an observational study.
Cicero S, Curcio P, Papageorghiou A, Sonek J, Nicolaides K.
Lancet 2001;358:1665-7. -
First trimester markers of trisomy 21 and the influence of maternal cigarette smoking status.
Spencer K, Ong CYT, Liao AWJ, Papademetriou D, Nicolaides KH.
Prenat Diagn 2000;20:852-3. -
First trimester prenatal diagnosis of trisomy 21 in discordant twins using fetal nuchal translucency thickness and maternal serum free beta-hCG and PAPP-A.
Spencer K, Nicolaides KH.
Prenat Diagn 2000;20:683-4. -
The influence of fetal sex in screening for trisomy 21 by fetal nuchal translucency, maternal serum free beta-hCG and PAPP-A at 10-14 weeks of gestation.
Spencer K, Ong CY, Liao AW, Papademetriou D, Nicolaides KH.
Prenat Diagn 2000;20:673-5. -
Is maternal serum total hCG a marker of trisomy 21 in the first trimester of pregnancy?
Spencer K, Berry E, Crossley JA, Aitken DA, Nicolaides KH.
Prenat Diagn 2000;20:311-7. -
Non-invasive assessment of endothelial function in normal pregnancy.
Savvidou MD, Kametas NA, Donald AE, Nicolaides KH.
Ultrasound Obstet Gynecol 2000;15:502-7. -
The relationship between leptin concentration and bone metabolism in the human fetus.
Ogueh O, Sooranna S, Nicolaides KH, Johnson MR.
J Clin Endocrinol Metab 2000;85:1997-9. -
The feto-placental unit stimulates the pregnancy-associated increase in maternal bone metabolism.
Ogueh O, Khastgir G, Abbas A, Jones J, Nicolaides KH, Studd JW, Alaghband-Zadeh J, Johnson MR.
Hum Reprod 2000;15:1834-7. -
Insulin-like growth factor binding protein-1 (IGFBP-1): a multifunctional role in the human female reproductive tract.
Fowler DJ, Nicolaides KH, Miell JP.
Hum Reprod Update 2000;6:495-504. -
Maternal age and gestation-specific risk for trisomy 21.
Snijders RJ, Sundberg K, Holzgreve W, Henry G, Nicolaides KH.
Ultrasound Obstet Gynecol 1999;13:167-70. -
Maternal serum S100 protein in normal and Down syndrome pregnancies.
Abraha HD, Noble PL, Nicolaides KH, Sherwood RA.
Prenat Diagn 1999;19:334-6. -
Collagen type VI gene expression in the skin of trisomy 21 fetuses.
von Kaisenberg CS, Brand-Saberi B, Christ B, Vallian S, Farzaneh F, Nicolaides KH.
Obstet Gynecol 1998;91:319-23. -
UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal-translucency thickness at 10-14 weeks of gestation.
Snijders RJ, Noble P, Sebire N, Souka A, Nicolaides KH.
Lancet 1998;352:343-6. -
Maternal and fetal insulin-like growth factors and their binding proteins in the second and third trimesters of human pregnancy.
Langford K, Nicolaides K, Miell JP.
Hum Reprod 1998;13:1389-93. -
Biochemical analyses of mesenchymal fluid in early pregnancy.
Jauniaux E, Gulbis B, Hyett J, Nicolaides KH.
Am J Obstet Gynecol 1998;178:765-9. -
First trimester urine free beta hCG, beta core, and total oestriol in pregnancies affected by Down's syndrome: implications for first-trimester screening with nuchal translucency and serum free beta hCG.
Spencer K, Noble P, Snijders RJ, Nicolaides KH.
Prenat Diagn 1997;17:525-38. -
Crown-chin length in normal and anencephalic fetuses at 10-14 weeks gestation.
Sepulveda W, Sebire NJ, Fung TY, Pipi E, Nicolaides KH.
Am J Obstet Gynecol 1997;176:852-5. -
Maternal serum alpha-fetoprotein in fetal neural tube and abdominal wall defects at 10-14 weeks of gestation.
Sebire NJ, Spencer K, Noble PL, Hughes K, Nicolaides KH.
BJOG 1997;104:849-51.